Nektar Therapeutics
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $1.54B
Liabilities Breakdown FY2020
Total Liabilities: $461.5M
Asset Breakdown
Total Assets: $1.54B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $199.0M | 12.9% |
| Accounts Receivable | $38.9M | 2.5% |
| Inventory | $15.3M | 1.0% |
| Property, Plant & Equipment | $59.7M | 3.9% |
| Goodwill | $76.5M | 5.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.15B | 74.7% |
Liabilities Breakdown
Total Liabilities: $461.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $22.1M | 4.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $439.3M | 95.2% |